製品名:1,3,4,6-Tetra-O-acetyl-beta-d-mannopyranose
IUPAC Name:[(2R,3R,4R,5S,6S)-3,4,6-tris(acetyloxy)-5-hydroxyoxan-2-yl]methyl acetate
Product Overview |
1,3,4,6-Tetra-O-acetyl-beta-d-mannopyranose, otherwise known as TA-4-M, is a sugar derivative found in many plants and fungi, including mushrooms, and is used in the synthesis of various compounds. TA-4-M is a highly polar molecule and has been the subject of much scientific research in recent years. |
Synthesis and Application |
TA-4-M is synthesized through a two-step process involving the acylation of mannose and the acetylation of the resulting intermediate. In the first step, mannose is reacted with an acylating agent, such as an alkyl halide, in the presence of a base, such as sodium hydroxide. The reaction yields the intermediate, 1,3,4,6-tetra-O-acyl-beta-d-mannopyranose. In the second step, the intermediate is reacted with acetic anhydride in the presence of a base, such as sodium hydroxide, to yield TA-4-M. TA-4-M has been used in a variety of scientific research applications, including drug delivery, gene therapy, and cancer research. In drug delivery, TA-4-M is used to transport drugs to specific tissues and organs, allowing for more efficient drug delivery and improved efficacy. In gene therapy, TA-4-M is used to deliver genes to cells, allowing for the introduction of new genetic material into cells. In cancer research, TA-4-M is used to deliver drugs to tumor cells, allowing for more targeted treatment of cancer. |
Future Directions |
The future of TA-4-M in scientific research is promising. One potential future direction is the development of new synthesis methods that allow for the production of TA-4-M in larger quantities and at lower costs. Another potential future direction is the development of new applications for TA-4-M, such as the use of TA-4-M in drug delivery systems and gene therapy. Additionally, further research into the biochemical and physiological effects of TA-4-M could lead to new and improved treatments for a variety of diseases. |